At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 1 Relative Bioavailability Study Comparing The Pharmacokinetics Of Aramchol Meglumine Granules For Oral Suspension To Aramchol Free Acid 300 mg Tablets In Healthy Volunteers
In Brief
A Phase 1 clinical trial evaluating Aramchol meglumine and Aramchol free acid for Healthy. Completed, enrolled 16 participants across 1 site.
Detailed Summary
This is a Phase 1 Relative Bioavailability Study Comparing The Pharmacokinetics Of Aramchol Meglumine (AM) Granules For Oral Suspension To Aramchol Free Acid (AA) 300 mg Tablets In Healthy Volunteers
Study Details
Timeline
Arms & Interventions
A single 400 mg dose of Aramchol meglumine will be administered to all study subjects in Period 1.
In Period 2, study subjects will be randomized 1:1 to receive Aramchol meglumine or 300 mg tablet of Aramchol free acid (Reference)
In Period 3, study subjects will be randomized 1:1 to receive Aramchol meglumine or 300 mg tablet of Aramchol free acid (Reference)
Interventions
Aramchol meglumine is a salt form of Aramchol free acid
Aramchol free acid is a fatty acid-bile acid conjugate